Home > Boards > US Listed > Medical - Equipment >

Titan Medical Inc. (TMDI)

Add TMDI Price Alert      Hide Sticky   Hide Intro
Moderator: dndodd, Honeycomb777, BigT82, SPORT19, livendi, SMirza_007
Search This Board: 
Last Post: 7/27/2021 5:16:13 PM - Followers: 494 - Board type: Free - Posts Today: 25


Titan Medical SPORT Surgical System
(Medtronic is a shot caller - up to $41M in Cash plus $1.5M Secured Loan)


July 2020 Titan Medical Corporate Presentation 

*As of mid-July 2020  55 issued patents and 85 patent applications pending


Surgeon Feedback From Initial Clinical Testing:

Ricardo Estape, M.D., a robotic gynecologic oncology surgeon from South Miami Gynecology Oncology Group who specializes in robotic single port surgeries, said, “The SPORT Surgical System performed beyond my expectations and I was able to complete a variety of critical surgical tasks with the necessary dexterity and precision through a single incision. The robotic instruments provided the necessary articulation, range of motion and rigidity along with 3D high-definition video on the flat panel monitor that allowed me to complete the surgery in a comfortable posture. This could be a game changer in gynecological surgery.”  SEE VIDEO

Eduardo Parra-Davila, M.D., a robotic colorectal surgeon at Florida Hospital who has trained thousands of surgeons worldwide on robotic surgery, commented, “Single port surgery without robotic assistance is not easy and yet it remains highly beneficial because of the desire to have fewer ports. It’s all about robotic articulation delivered through a single incision that allows for the reach, necessary angles and multi-quadrant access to treat diseases in colorectal surgeries. The SPORT Surgical System has the promise to become a valuable tool for all robotic surgeons looking to do single port surgery in the future.”    SEE VIDEO

Arnold Advincula, M.D., Chief of Gynecologic Specialty Surgery at Columbia University and an expert in robotic surgery, said, “After using the SPORT system, I am more convinced that single-port robotic surgery could become a reality for many patients. Previous approaches to single-incision surgery have been limiting and ineffective. The SPORT system demonstrated that it can not only address those limitations, but it may also provide some unique capabilities for enabling a variety of gynecologic surgeries through a single incision. The future of single-port robotic surgery is bright and I am excited to actively participate in this journey with Titan Medical.”

Vipul Patel, M.D., a world-renowned robotic urology surgeon from the Global Robotics Institute at Florida Hospital and the only surgeon in the world to have completed 10,000 robotic prostatectomies, said, “Although multi-port robotic prostatectomy is currently the standard of care in urology, single port robotic surgery could be the next frontier in urology and other surgical disciplines. It was exciting for me to use Titan Medical’s SPORT system at Florida Hospital Nicholson Center. The technological capabilities of the SPORT system are very encouraging and the early success in establishing feasibility is an important step in the right direction.”

William Burke, M.D., a gynecologic oncologist at Stony Brook University Hospital with extensive robotic surgery experience, commented, “Having completed thousands of multi-port robotic surgeries over several years of practice, I was pleased with the capabilities of the SPORT system that eased my transition from a multi-port approach to single-port robotic surgery. The workspace, access and ease of use while maintaining critical multi-port robotic features such as multi-articulated instruments and high-definition 3D visualization through a single incision, are important factors in transitioning from multi-port to single-port robotic surgery. I must say that the SPORT system, with its sophistication, makes a highly compelling case for single-port robotic surgery.”

Lee Swanstrom, MD, FACS, Chief Innovation Officer of IHU Strasbourg, said, “I was pleased with my first experience with the SPORT system for applications in abdominal procedures. There are many patients undergoing general surgical procedures who could greatly benefit from a reduced number of incisions. Single-port robotic surgery can be a truly enabling solution for patients and surgeons alike, and it is exciting to see that the SPORT system takes us much closer to that possibility.”

Jelle Ruurda, MD, a gastrointestinal and oncologic surgeon at University Medical Center Utrecht, who has several years of robotic surgery experience, commented, “Many oncologic general surgery procedures require specimen retrieval at the end of the procedure. These procedures are natural applications for single-port robotic surgery. My first operation of the SPORT system in a preclinical environment was very exciting, and the system shows great promise for future clinical use. I look forward to the opportunity to work together with Titan Medical to evolve a single-port robotic surgery option for my oncology patients. Based on this first experience, I am confident that single-port robotic surgery has a bright future”.

Eric Barret, MD, a world-renowned robotic urologic surgeon at Institut Mutualiste Montsouris, said, “Having performed many single-incision robotic surgeries with flexible, non-wristed and crossed-over instruments, my first experience with the SPORT system was exceptional. The SPORT system addresses many limitations of previous laparoscopic and robotic single-incision surgery approaches, and holds significant promise for meaningful use in urologic applications.”


SPORT™ Surgical System

A robotic system like no other!

The SPORT Surgical System is a versatile single incision advanced robotic surgical system that features state-of the-art multi-articulated instruments with single-use replaceable tips, 3D high definition visualization on a flat-screen monitor, ergonomic open workstation and a single-arm mobile patient cart for ease of set up while enabling broad applications of single and multi-quadrant surgeries previously not possible with current robotic solutions.

Titan Medical Inc. is a Canadian public company, headquartered in Toronto, Ontario, that trades on the Toronto Stock Exchange (TMD) and the OTCQX in the United States (TITXF). Titan is developing the SPORT™ (Single Port Orifice Robotic Technology) Surgical System for use in minimally invasive surgery (“MIS”) that is expected to be commercially available in 2019. Titan’s robotic surgical system is being designed to expand robotic surgery into areas that are currently underserviced. This will allow surgeons to perform procedures within small to medium size surgical spaces such as general surgery and cholecystectomy. Currently, the most common medical procedures for which robotic systems are used are hysterectomies and prostatectomies. Titan plans to expand the scope and obtain approval for various surgical procedures as outlined in their Corporate Presentation.   http://www.titanmedicalinc.com/

The SPORT™ Surgical System includes the following:
* a single-port surgeon controlled robotic platform that includes a 3D vision system and interactive instruments for performing MIS procedures, and * a surgeon workstation that provides the surgeon with an interface to the robotic platform   for controlling the interactive instruments and providing a 3D endoscopic view of inside a patient’s body during MIS procedures.

David J. McNally, Chief Executive Officer, Director


Mr. McNally joins Titan after serving as the founder, President, CEO and Chairman of the Board of Domain Surgical Inc., founded in 2009, Domain is based in Salt Lake City, Utah. Mr. McNally brings substantial experience in areas of extraordinary leadership skills with all facets of building innovative medical device companies including clinically-focused product design and development, capital formation, regulatory clearance, and commercialization. Mr. McNally earned an MBA from the University of Utah, holds a Bachelor of Science degree in Mechanical Engineering from Lafayette College, Easton, PA and is the co-inventor of more than 30 U.S. and international patents associated with ferromagnetic surgical devices and systems, electromagnetic and ultrasonic sensors, and medical fluid delivery systems


                                                                                  Surgeon Advisory Board

Arnold Advincula, MD

Dr. Advincula is Vice-Chair of Women’s Health & Chief of Gynecology at the Sloane Hospital for Women, Columbia University Medical Center/New York Presbyterian Hospital. Formerly, he was Professor of Obstetrics and Gynecology, Director of the Minimally Invasive Surgery Division and Fellowship, and Director of the Endometriosis Center at the University of Michigan. More recently, he was Director of the Center for Specialized Gynecology and Director of the Education Institute at the Nicholson Center, an advanced medical and surgical simulation training facility at Florida Health. He is currently Vice President of the American Association of Gynecologic Laparoscopy and a Member-at-Large for the Society of Gynecologic Surgeons. He is a leader in minimally invasive surgical techniques and one of the world’s most experienced gynecologic robotic surgeons, who has published and taught extensively in the area of minimally invasive surgery, as well as developed surgical instruments that are in use worldwide.

Juliane Bingener-Casey, MD

Dr. Juliane Bingener is Professor of Surgery, Mayo Clinic College of Medicine, and Vice Chair for Quality, Safety and Service in the Mayo Clinic Department of Surgery. She has a joint appointment in the Division of Gastroenterology and Hepatology, which supports her clinical interests in minimally invasive surgery, endoscopy, and gastrointestinal disease. Her research focuses on patient reported outcomes and novel technology in the diagnosis and treatment of these diseases. Dr. Bingener’s previous work included the development of a Natural Orifice Translumenal Endoscopic Surgery (NOTES) technique for using an omental patch to close perforated ulcers. Her ongoing interests focus on the development, study, and implementation of innovative endoscopic and laparoscopic approaches for gastrointestinal diseases.

W. Douglas Boyd, MD

Dr. Boyd is a Professor of Surgery and Director of Robotics and Biosurgery at the University of California Davis. He is Head of Adult Cardiac Surgery and Surgical Director of the Transcatheter Valve Program. He is recognized for his pioneering work in cardiothoracic surgery and for his use of robotic-assisted surgical systems. He specializes in minimally invasive cardiac and robotic-assisted heart surgery. Dr. Boyd completed the world’s first closed-chest, beating-heart coronary artery bypass surgery using a robotic system in 1999. Prior to his appointment as a professor of surgery at UC Davis Health System, Dr. Boyd served as chair of the Department of Cardiothoracic Surgery at the Cleveland Clinic in Florida. As the author of more than 70 peer-reviewed, journal articles, Dr. Boyd’s research interests include cardiac tissue regeneration using extracellular matrix/stem cells, new techniques for robot-assisted minimally invasive coronary artery revascularization, valve surgery and tele-surgery. He is a graduate of Carleton University in Ottawa, Canada and obtained his medical degree from the University of Ottawa, Canada.

Demetrius EM Litwin, MD, MBA, FRCS, FACS, FICS

Dr. Litwin trained in General Surgery at the University of Saskatchewan, and completed a hepatobiliary fellowship at the University of Toronto. He was an early pioneer in laparoscopic surgery, having performed the first laparoscopic cholecystectomy in Western Canada in 1990 and the first laparoscopic colectomy in Canada in 1991. He was a leader in educating a large number of surgeons across Canada in basic and advanced laparoscopic techniques. During the early advent of minimally invasive surgery, he innovated new laparoscopic approaches to the spine and aorta, and he participated in the development of HandPortTM, a hand assist device for laparoscopic surgery. In 1993, Dr. Litwin became the Director of Minimally Invasive Surgery at the University of Toronto. In 1997, he moved to the University of Massachusetts as Chief of Minimally Invasive Surgery. Since 2004, he has been Chairman of Surgery at the University of Massachusetts Medical School and UMass Memorial Medical Center, one of the largest Academic Health Sciences Centers in Massachusetts. There, he continues to practice minimally invasive surgery of the abdomen in addition to his administrative role.

Lee L Swanstrom, MD, FACS

Dr. Swanstrom heads the Division of GI and Minimally Invasive Surgery at the Oregon Clinic and is Director of the Providence Health System’s Complex GI and Foregut Surgery Postgraduate Fellowship Program. In addition, he is Clinical Professor in the Department of Surgery at OHSU, a Director of the American Board of Surgery, and Past President of both the Society of American Gastrointestinal Endoscopic Surgeons (SAGES) and the Fellowship Council (FC). Most recently, he became the Chief Innovations Officer and Director of the Innovations Fellowship at the Institutes des Hôpitalo Universitaires of the University of Strasbourg, France. He is the editor of Surgical Innovation and the author of over 300 scientific papers and 50 book chapters. This has resulted in 13 patents and a successful medical device startup company. He is and has been an investigator on numerous outcomes research studies for new procedures such as Natural Orifice Translumenal Endoscopic Surgery (NOTES) to determine their safety and efficacy for establishing new standards of care. He remains focused on developing innovative approaches to the minimally invasive treatment of foregut and other gastrointestinal disorders.

John Valvo, MD

Dr. Valvo, a practicing surgeon, is the Executive Director of Robotic and Minimally Invasive Surgery at Rochester General Hospital in Rochester, New York, where he formerly was the Chief of Urology. Following a 20-year career performing open surgery, Dr. Valvo founded the robotic surgery program at Rochester General Hospital in early 2004, which currently ranks in the top two percent of robotic surgery volume in the United States. The program has trained over 30 robotic surgeons and enabled the completion of more than 7,000 robotic urology, gynecology, general and colorectal surgeries to date. Dr. Valvo has authored more than 100 scientific articles and helped start many robotic programs in the northeast. His focus on robotic surgery credentialing led to a notable published paper on policy guidelines for robotic surgery. He is a fellow of the American College of Surgeons and American Urological Association, and a member of the Society for Laparoscopic Surgeons. 



Titan's leader



  Patent #                                                    Title of Invention
1 8,930,027   Force Feedback System
2 8,792,688   Methods, systems and devices for three dimensional input and control methods and systems based thereon
3 8,768,509   Snaking robotic arm with movable shapers
4 8,347,754   Multi articulating robotic instrument
5 8,332,072   Robotic hand controller
6 8,306,656   Method and system for performing medical procedure
7 8,224,485   Snaking robotic arm with movable shapers
8 5,853,394   Catheter
9 5,607,407   Catheter assembly
10 4,785,868   Medical needle and method for making
  PUB. APP. NO.  Title

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
TMDI News: Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) 07/22/2021 07:31:45 AM
TMDI News: Titan Medical to Participate in Alliance Global Partners Virtual MedTech Summer Investor Conference 07/22/2021 07:30:00 AM
TMDI News: Titan Medical Announces Appointment of New Chief Financial Officer 07/12/2021 07:30:00 AM
TMDI News: Titan Medical Reports Voting Results From Annual and Special Meeting of Shareholders 06/10/2021 07:30:00 AM
TMDI News: Titan Medical Receives License Fee of $10 Million Upon Achievement of Milestone Under Medtronic Development Agreement 05/28/2021 07:30:00 AM
#129874  Sticky Note Here. Ill do it for u... Helen has Jojo45 07/13/21 01:28:10 PM
#129841  Sticky Note Ok - we gonna take it REAL SLOW Honeycomb777 07/13/21 10:21:45 AM
#121725  Sticky Note Copied from my InvestorVillage post... 66Mustang 12/30/20 01:43:29 PM
#130397   1.57 is 528% up for those that bought Jojo45 07/27/21 05:16:13 PM
#130391   We’re…… Times Yours 07/27/21 04:30:49 PM
#130390   Wrong! Just like IREP, wrong! It’s $1.57 RockoTaco 07/27/21 04:16:36 PM
#130380   1.52 SPORT19 07/27/21 11:37:42 AM
#130378   Well We’re waiting…….. Times Yours 07/27/21 11:05:27 AM
#130377   Soooo funny. What has changed pal? The whole Brave11 07/27/21 10:51:15 AM
#130376   1.54 Tic Toc? SPORT19 07/27/21 10:47:53 AM
#130375   ScoooooooooooooopEM!! Adrock 07/27/21 10:29:32 AM
#130374   Thanks for the update. Thats 524% gain Jojo45 07/27/21 10:22:32 AM
#130373   1.55 SPORT19 07/27/21 10:11:01 AM
#130372   Reply 130364: Shorts, thank you for that. BIGKAHUNA57 07/26/21 10:57:42 PM
#130371   Great post. Thanks. Drink much ? timteo 07/26/21 09:12:41 PM
#130368   What’s your stance on the sell for tax RockoTaco 07/26/21 07:54:39 PM
#130367   u will need a sp and mp to livendi 07/26/21 06:15:56 PM
#130366   First, I want to say I'm bullish on Ohnototo 07/26/21 06:05:07 PM
#130365   Their use of “single orifice” here is precarious. Brave11 07/26/21 05:33:32 PM
#130364   "Our Vision ShortsRClowns 07/26/21 05:15:04 PM
#130363   https://www.fool.ca/2021/05/25/value-investors-1-pharma-stock-with-huge-potentia SMirza_007 07/26/21 04:21:46 PM
#130362   Your forgetting the point, if the share price SMirza_007 07/26/21 04:21:04 PM
#130361   frequent1, another good post here; thank you for 66Mustang 07/26/21 04:10:00 PM
#130359   I remember this. It helped the stock Geo2014 07/26/21 11:44:49 AM
#130357   All longs tax harvested a long time ago. Times Yours 07/26/21 11:09:55 AM
#130355   If this sells for $12 per share, I OR Nurse 07/26/21 10:53:30 AM
#130354   All good points. We won’t know until Times Yours 07/26/21 10:48:59 AM
#130353   Just something to consider. We went from building frequent1 07/26/21 10:39:13 AM
#130352   ABSOLUTE CRAP. He made exact same bs prediction BelizeMe 07/26/21 10:15:08 AM
#130350   Smirza, nice find! 66Mustang 07/26/21 08:34:45 AM
#130349   69 days or sooner until big news!! OR Nurse 07/26/21 08:24:13 AM
#130348   Bro that’s from 7 years ago Bamadan21 07/26/21 06:49:03 AM
#130347   https://seekingalpha.com/instablog/1282351-steve-rosenman/3029695-titan-medical- SMirza_007 07/26/21 04:53:28 AM
#130346   Of course u won’t guarantee it bc after RockoTaco 07/25/21 10:34:34 PM
#130345   Helen? You keep forgetting that some have BIGKAHUNA57 07/25/21 10:03:38 PM
#130343   If u can’t get this to $1.40 this RockoTaco 07/25/21 08:38:51 PM
#130342   Who’s taking losses? I’m not, newbies aren’t! RockoTaco 07/25/21 08:36:21 PM
#130341   I don’t believe you can take it down RockoTaco 07/25/21 08:35:15 PM
#130340   It does you little good to wait as Honeycomb777 07/25/21 08:09:53 PM
#130339   It’s called reading, left to right, put words RockoTaco 07/25/21 08:09:22 PM
#130338   Obviously u don’t dispute the math and anyone RockoTaco 07/25/21 08:01:29 PM
#130337   why is it so HUGE ? Ain't Honeycomb777 07/25/21 07:48:41 PM
#130336   Waiting 30 days after selling at this point RockoTaco 07/25/21 07:28:35 PM
#130335   MEDTRONIC WILL STICK TO suckitup 07/25/21 06:19:42 PM
#130334   tmdi to da moon,god bless all livendi 07/25/21 02:16:44 PM
#130333   70 days or sooner!!! OR Nurse 07/25/21 01:40:51 PM
#130332   Timing and free advice, BIGKAHUNA57 07/25/21 11:04:49 AM
#130331   pontiac....see you in Vegas! bidds 07/25/21 10:41:18 AM
#130330   it’s honestly tough to fathom a stock going pontiacg6 07/24/21 11:00:31 PM
#130322   Exactly bk. Well said. Jojo45 07/24/21 06:59:39 PM
#130321   71 days or sooner!!! Tic Toc!!! OR Nurse 07/24/21 06:12:46 PM
#130320   Sometimes patience can be everything livendi 07/24/21 05:37:53 PM
#130319  Restored Like I said, the miscalculation was that there RockoTaco 07/24/21 05:21:39 PM
Consent Preferences